loader
Please Wait
Applying Filters...
menu
    • menu

    Products Under Development 2025 services provided by Mankind Pharma

    Virtual BoothMenuMankind Pharma
    Products Under Development 2025

    PDF Upload Mar, 2025
    News
    Mankind’s Generics Sitagliptin Receives Tentative Approval in US

    21 May 2026

    // FDA

    Mankind Pharma Profit Jumps 30% On Chronic Therapy Demand In Q4

    20 May 2026

    // ECONOMICTIMES

    Indian Drugmaker Mankind Posts Strong Q Profit on Chronic Demand

    19 May 2026

    // REUTERS

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI China

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/8TC5EWpA250
    Xls

    CATEGORY PAGE
    Menu

    Mankind Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI71770
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.